Heart Failure

The drug reduced cardiovascular risk in people with prior heart attack and inflammatory atherosclerosis.

Using the database from the 40-country, double-blind phase 3 ARISTOTLE study, which has been around for over 5 years, a sub-analysis was conducted by Renato Lopes, MD, PhD, professor of Medicine at Duke University in Durham, North Carolina and colleagues.

The Absorb GT1 Bioresorbable Vascular Stent raised concerns at the FDA.

Drugs were as effective in CTO patients as PCI, Korean study found.

Endotracheal intubation may do more harm than good.

In just over a year, Praluent has shown benefits in helping patients lower their cholesterol level. Despite the progress, there have also been some challenges.

The mysterious sudden deaths of apparently healthy people, some young and engaged in sports, could be explained by mutations uncovered by a Canada research team.

Even after the implantation of a left ventricular assist device there is no guarantee that patients will live much past the procedure. Planning for life after the implant can be as important as the time beforehand.

For many, cardiovascular disease can be seen as mostly an issue facing men. However, work has been done to raise the education of women to help ensure their health as well.

At the Heart Failure Society of America's 20th Annual Scientific Meeting, Pieter Muntendam, MD, scPharmaceuticals, discussed his work in developing a hospital strength treatment option for patients with fluid overload using the well known drug furosemide, now for subcutaneous administration.

Study results presented at the 2016 Heart Failure Society of America Scientific Meeting show that treatment with omecantiv mecarbil improved cardiac function and quality of life in patients with heart failure.

There is a known connection between atrial fibrillation and stroke risk. Finding the best way to handle this connection can determine the success of care and the quality of life for patients.

Statins should not be physicians' first option in treating all patients at high risk of cardiovascular disease, according to new European treatment guidelines.

Pope Francis plans to appear at the ESC Congress 2016 to endorse the group's healthy lifestyle campaign.

While some patients may need procedures like gastric bypass surgery to lose weight others may be able to achieve their goals by taking smaller steps.

There are many patients around the world suffering from various degrees of heart failure. With such potentially fatal consequences there has been a push to make the condition only treated by specialists.

When most people think of palliative care their first thought is likely to hospice and end of life oncology care, but experts in the field are working to change and expand that perception to other areas of health care as well.

The approval of medications like statins and PCSK9 inhibitors to help lower cholesterol levels have proven helpful but a recent study looked at whether patients were getting not only the treatments they needed but whether they were getting the right dosage levels to help improve their health.

As new medications are introduced to the market there can be some hesitation by doctors to make the jump from more traditional treatment options. Moving beyond that has shown benefits for a patient's long term health.